TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer

QR Code

TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer

Background Natural killer (NK) cells provide important immune protection from cancer and are a key requirement for particular immunotherapies. There is accumulating evidence that NK cells become dysfunctional during cancer. Overcoming NK cell exhaustion would be an important step to allow them to fu...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Michael Conroy, John Kennedy, Karen Slattery, Elena Woods, Vanessa Zaiatz-Bittencourt, Sam Marks, Sonya Chew, Caitriona Goggin, Colm MacEochagain, Sophie Lucas, David K Finlay, Clair M Gardiner
Format:	article
Langue:	EN
Publié:	BMJ Publishing Group 2021
Sujets:	Neoplasms. Tumors. Oncology. Including cancer and carcinogens RC254-282
Accès en ligne:	https://doaj.org/article/b8a8d841ff7e409c8d04b1a423e2c8fe
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Specific human cytomegalovirus signature detected in NK cell metabolic changes post vaccination
par: Elena Woods, et autres
Publié: (2021)

Correction: TGFβ drives NK cell metabolic dysfunction in human metastatic breast cancer
Publié: (2021)

Dual roles of neutrophils in metastatic colonization are governed by the host NK cell status
par: Peishan Li, et autres
Publié: (2020)

Advances in Immunotherapy and the TGF-β Resistance Pathway in Metastatic Bladder Cancer
par: David J. Benjamin, et autres
Publié: (2021)

Amino acid-dependent cMyc expression is essential for NK cell metabolic and functional responses in mice
par: Róisín M. Loftus, et autres
Publié: (2018)

Activin signaling is an essential component of the TGF-β induced pro-metastatic phenotype in colorectal cancer
par: Jonas J. Staudacher, et autres
Publié: (2017)

Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity.
par: Erica B Wilson, et autres
Publié: (2011)

A Promising Role of TGF-β Pathway in Response to Regorafenib in Metastatic Colorectal Cancer: A Case Report
par: Simona De Summa, et autres
Publié: (2021)

Current Perspectives on “Off-The-Shelf” Allogeneic NK and CAR-NK Cell Therapies
par: Erica L. Heipertz, et autres
Publié: (2021)

Identification of microRNAs inhibiting TGF-β-induced IL-11 production in bone metastatic breast cancer cells.
par: Sirkku Pollari, et autres
Publié: (2012)

TGFβ2-induced formation of lipid droplets supports acidosis-driven EMT and the metastatic spreading of cancer cells
par: Cyril Corbet, et autres
Publié: (2020)

Metabolic requirements of NK cells during the acute response against retroviral infection
par: Elisabeth Littwitz-Salomon, et autres
Publié: (2021)

NK cell-like behavior of Valpha14i NK T cells during MCMV infection.
par: Johnna D Wesley, et autres
Publié: (2008)

Activated NK cells cause placental dysfunction and miscarriages in fetal alloimmune thrombocytopenia
par: Issaka Yougbaré, et autres
Publié: (2017)

NK cell-derived IL-10 is critical for DC-NK cell dialogue at the maternal-fetal interface
par: Sandra M. Blois, et autres
Publié: (2017)

EBV Positive Aggressive NK-Cell Leukemia
par: Ankitha Hebbar, et autres
Publié: (2021)

PECULIARITIES OF NK CELLS DIFFERENTIATION: CD56dim AND CD56bright NK CELLS AT PREGNANCY AND IN NON-PREGNANT STATE
par: V. A. Mikhailova, et autres
Publié: (2017)

Linfoma T/NK extraganglionar tipo nasal: Caso clínico
par: Alvarez N,Candelas, et autres
Publié: (2017)

NK Cell Regulation in Cervical Cancer and Strategies for Immunotherapy
par: Adriana Gutiérrez-Hoya, et autres
Publié: (2021)

Salivary gland NK cells are phenotypically and functionally unique.
par: Marlowe S Tessmer, et autres
Publié: (2011)

HETEROGENEITY OF NK AND NKT LYMPHOCYTE POPULATIONS IN HEALTHY DONORS
par: D V. Tabakov, et autres
Publié: (2017)

Atividade Antileucêmica das Células Natural Killer (NK)
par: Aline Almeida Oliveira, et autres
Publié: (2008)

A RARE CASE: POSTTRANSPLANT NK/T CELL LYMPHOMA
par: Pınar Tığlıoğlu, et autres
Publié: (2021)

Observation of the decays χ cJ → nK S 0 Λ ¯ $$ {\mathrm{nK}}_{\mathrm{S}}^0\overline{\Lambda} $$ + c.c.
par: The BESIII collaboration, et autres
Publié: (2021)

Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP<sub>2</sub> in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients
par: Stanley Du Preez, et autres
Publié: (2021)

Blockade of immunosuppressive cytokines restores NK cell antiviral function in chronic hepatitis B virus infection.
par: Dimitra Peppa, et autres
Publié: (2010)

MAIT cells regulate NK cell-mediated tumor immunity
par: Emma V. Petley, et autres
Publié: (2021)

Sarcoma IL-12 overexpression facilitates NK cell immunomodulation
par: Mary Jo Rademacher, et autres
Publié: (2021)

FEATURES OF NK-CELL CONTENTS IN PATIENTS WITH CHRONIC HEPATITIS C
par: M. S. Selkova, et autres
Publié: (2014)

NK and T Cell Immunological Signatures in Hospitalized Patients with COVID-19
par: Laura Bergantini, et autres
Publié: (2021)

ASSESSING EFFECTS OF CUCURBITURILS ON MONOCYTES AND NK-CELLS IN HEALTHY VOLUNTEERS
par: A. A. Aktanova, et autres
Publié: (2021)

Expression of CD226 is associated to but not required for NK cell education
par: Arnika K. Wagner, et autres
Publié: (2017)

Reevaluation of NOD/SCID Mice as NK Cell-Deficient Models
par: Miao Miao, et autres
Publié: (2021)

Targetable vulnerabilities in T- and NK-cell lymphomas identified through preclinical models
par: Samuel Y. Ng, et autres
Publié: (2018)

The Biological Role and Therapeutic Potential of NK Cells in Hematological and Solid Tumors
par: Rodion A. Velichinskii, et autres
Publié: (2021)

Repression of GSK3 restores NK cell cytotoxicity in AML patients
par: Reshmi Parameswaran, et autres
Publié: (2016)

The Role of TGF-β in Bone Metastases
par: Trupti Trivedi, et autres
Publié: (2021)

TGF-ß and New Bone Formation
par: Issa,João Paulo Mardegan, et autres
Publié: (2006)

Dynamic shift from CD85j/ILT-2 to NKG2D NK receptor expression pattern on human decidual NK during the first trimester of pregnancy.
par: Romain Marlin, et autres
Publié: (2012)

Discordance of the estrogen receptor and HER-2/neu in breast cancer from primary lesion to first and second metastatic site
par: Lower EE, et autres
Publié: (2017)